Intermountain Healthcare to Sponsor Wasatch Speaker Series

Partnership brings prominent speakers to Utah for engaging, thought-provoking forum

SALT LAKE CITY, UTAH, USA, September 19, 2017 / — Intermountain Healthcare is now the exclusive presenting sponsor of the Wasatch Speaker Series, the two organizations announced. Both organizations share a strong commitment to delivering important community benefits to the greater Salt Lake City area and the state of Utah. This partnership further delivers on that promise, and helps to establish the fast-growing Salt Lake City area as a national cultural center.

“Our objective from the start has been to bring Utah, for the first time, world-class luminaries from various disciplines in a close up and personal speaking experience. We want the Wasatch Speaker Series to be the premier speaker forum in the country, and having participation and support from an important community leader like Intermountain Healthcare helps to make this a reality,” stated Gary Lauer, President of the Wasatch Speaker Series.

“Having access to leading thinkers who give us important insights and promote thoughtful conversations is a hallmark of a healthy communities,” added Marc Harrison, MD, president and CEO of Intermountain Healthcare. “We’re pleased to be part of what promises to be an excellent series.”

Intermountain Healthcare is a not-for-profit health system based in Salt Lake City, Utah, with 22 hospitals, a broad range of clinics and services, about 1,500 employed primary care and secondary care physicians at more than 180 clinics in the Intermountain Medical Group, and health insurance plans from SelectHealth. Intermountain regularly participates in national and international forums focused on healthcare transformation and leadership, innovation, and building healthy communities.

The Wasatch Speaker Series is a powerful seven-evening session of intimate speaking engagements and audience Q&A with luminaries of our time, taking place at Abravanel Hall in downtown Salt Lake City from Oct. 4, 2017, through March 29, 2018. This inaugural season features speakers including former VP Joe Biden, Dr. Jane Goodall, Dr. Sanjay Gupta, Astronaut Scott Kelly, Gen. Martin Dempsey, Paul Nicklen, and Jane Pauley. More information can be found and season tickets can be ordered at

Daron Cowley
Intermountain Healthcare
email us here

Source: EIN Presswire

Giving U the X-Factor [with Isomorphic Software]

Giving U the X-factor: SmartClient 11.1 | 6.1

Today, Isomorphic Software – provider of the most advanced, most complete HTML5 platform for building Enterprise web apps – released SmartClient 11.1 | 6.1.

SAN FRANCISCO, CA, UNITED STATES, September 19, 2017 / — To help illustrate the significance of Isomorphic's SmartClient 11.1 | 6.1, imagine you’re attracted to someone in a bar. They likely won’t give you the time of day unless they find you easy on the eye. If you pass that hurdle, you’ll probably get a date. But if you can’t hold at least a basic conversation about the performance benefits of Adaptive Filtering, the relationship is over before it even gets started.

Adoption of Enterprise web applications works in much the same way. When users first check out your new offering, they’ll quickly formulate an opinion. If it’s negative, you’re dead in the water. If they like what they see, they’ll test further to weigh-up whether it will make their job easier. If capabilities are found lacking, getting adoption will be a losing battle.

That’s why you need Isomorphic’s latest release, SmartClient 11.1 | 6.1. It is the best looking technology for building Enterprise web applications (see their new ‘Tahoe’ skin: attention to detail, contemporary, beautiful). Your apps will be getting much more than a second glance. Beyond the superficial, SmartClient gives your applications a depth and breadth of capabilities that is unrivaled: Enterprise Grade UI components, Intelligent Data Management, and Deep Server Integration. With Isomorphic’s SmartClient, you had better be ready for some serious, long term relationships.

SmartClient 11.1 | 6.1 is available for download today. It adds contemporary UI/UX, intelligent charts that adapt to dynamic data, and numerous productivity features. Learn more at

About Isomorphic Software
Isomorphic Software is based in San Francisco and has over a decade of industry leadership, providing technology platforms for building enterprise web applications. Companies around the world use the SmartClient Platform, including Cisco, Boeing, Toyota, Philips and Genentech. 

Isomorphic Software
(866) 223-4569
email us here

Source: EIN Presswire Digital Agency Sends Families to the Phillies Game

Cancer patients find an escape at Citizens Bank Park.

PHILADELPHIA, PA, USA, September 19, 2017 / — Last Sunday, four different families enjoyed a day at the ballpark thanks to Digital Agency, who raised and donated funds to For Pete’s Sake Cancer Respite Foundation (FPS).

Although the Phillies fell to the Oakland Athletics 6-3 in the last of a three-game series, there was still something special to be celebrated: the opportunity for families to forget about treatments and doctor's visits for at least a little while as they created lasting memories with loved ones.

FPS is a non-profit organization located in Plymouth Meeting, PA that enables cancer patients and their loved ones to strengthen, deepen and unify their relationships by creating lasting and unforgettable respite vacations.

Once the families return from their trips, FPS provides additional emotional support and opportunities for the patients, caregivers and kids to create more memories at FPS fundraising events, sporting events and at amusement parks.

“This was an amazing event for everybody involved,” said Lance Bachmann, President & CEO of 1SEO. “I hope each of the families had a great time. I’m really proud of my team for making this possible.” Digital Agency is a custom web design company that specializes in SEO, pay per click advertising, social media marketing and much more. Throughout their eight years in business, giving back to the community has always been a priority for 1SEO.

“Family is so important in life,” Bachmann said. “So to give these patients a chance to spend time with their families, share some laughs and, for the first time in a while, just enjoy the present moment, is something we’re really happy about.”

As of now, the Phillies are on track to finish in last-place of the National League East. However, events like these serve as reminders of what a day at the ballpark is all about. And they also help patients recognize that it’s not cancer that defines them but the courage and bravery that they’re able tap into as they battle the disease.

Anyone interested in donating to FPS can do so by reaching out to the foundation at People can also find out more information about the services available through Digital Agency by visiting their website or calling 855-335-6239 today.

About Digital Agency Digital Agency is a Philadelphia, PA-based digital marketing firm that provides end-to-end solutions for their clientele, which is comprised of hundreds of businesses in countless industries that operate in several sectors, from the niche to the mainstream. Using a full suite of services like search engine optimization (SEO), pay per click (PPC), social media optimization (SMO), website design, content writing and email marketing, Digital Agency helps their clients win online by cultivating online presences and harvesting leads, closes, conversions and profits.

For more information, please visit

Rachel Lawler Digital Agency
email us here

Source: EIN Presswire

Best-Selling Children Series Harry Moon and Dana-Farber Cancer Institute Join Forces For Pediatric Cancers

The Dana-Farber Cancer Institute

Harry Moon is about young heroes who inspire us with their gentleness and kindness. We want to support the important work that Dana-Farber is doing to save children's lives.”

— Mark Andrew Poe, Author of Halloween Nightmares

BOSTON, MA, USA, September 19, 2017 / — Dana-Farber Cancer Institute and the popular children's series, Harry Moon, announced they are teaming up to fight pediatric cancers by directing a portion of the book sales to Dana-Farber Cancer Institute. Thousands of young Harry Moon readers from around the country will be helping to raise funds by purchasing these books.

"Every year, more than 10,000 children in the United States are diagnosed with cancer, news that no family wants to hear,” says Lisa Diller, MD, Chief Medical Officer, Dana-Farber/ Boston Children's Hospital Cancer Center and director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. "Fortunately, advances in research and care have dramatically increased survival rates for children with cancer, and we are better addressing treatment side-effects to help patients live full, healthy lives."

The series publisher, Rabbit, has launched the Harry Moon Book Club Catalog, which will be offered five times a year to parents, schools, and corporations around the United States. The color catalogs contain more than twenty specially-priced Harry Moon and Honey Moon titles. A portion of the proceeds will be directed to Dana Farber Cancer Institute for pediatric cancer care and research.

“When a child is diagnosed with cancer, it releases a hero. The story of Harry Moon is about young heroes who inspire us with their gentleness and kindness. We want to support the important work that Dana-Farber is doing to save children's lives and bring our readers and these young heroes together,” says series author, Mark Andrew Poe.

The Harry Moon series is distributed worldwide by Diamond Comic Distributors. For more information about the Harry Moon Book Club, including resources and information about cancer prevention and screening, visit

Ted Snow
Rabbit Publishers
(847) 259-2100
email us here

Source: EIN Presswire

Info Cubic achieves new ISO 9001:2015 Certification.

Info Cubic, LLC, a leading employment screening company, is proud to announce that we have achieved ISO 9001:2015 Certification.

DENVER, COLORADO, USA, September 19, 2017 / — Info Cubic, LLC, a leading employment screening company, is proud to announce that we have achieved ISO 9001:2015 Certification.

The International Organization for Standardization (ISO) was formed in 1947. Today, ISO is an independent, non-governmental international organization with members from 162 countries and 786 technical bodies. They have created more than 21,000 International Standards containing practical information and best practices and often describe an agreed way of doing something or a solution to a global problem.

“We’ve been ISO 9001:2008 Certified since October of 2010 but wanted to continue to push our organization to be the best that it can be” said Eden Hutchinson, Info Cubic’s Manager of Quality Assurance. “The new ISO 9001:2015 Standard is more up-to-date and reflective of service orientated organizations allowing us to achieve conformity of products and services in our efforts to exceed our clients’ needs and expectations.”

Info Cubic’s long time focus on quality and client service is at the very core of our business. The Plan-Do-Check-Act cycle (PDCA) is a natural fit in our operations and service departments.

While anyone can claim to be the best in the industry, Info Cubic’s ISO 9001:2015 Certification, NAPBS Accreditation and back to back Bakers Dozen awards for Customer Service are all concrete proof that we are committed to doing what we say we’re going to do and that we have substantiating evidence to back it up.

Imagine…working with people who love what they do!

About Info Cubic
Headquartered in Denver, Colorado, Info Cubic LLC is a leading provider of employment screening and drug testing for organizations of any size and structure. Info Cubic prides itself on providing first-class customer service, industry-leading turnaround times, maximum accuracy and legal compliance expertise. Info Cubic is accredited through the National Association of Professional Background Screeners (NAPBS), ISO 9001:2015 certified, Workforce Magazine Hot Listed and multi-year award winners of HRO Today Baker’s Dozen Customer Satisfaction Ratings. Visit or call (877) 360-INFO (4636) for additional information.

Jason Rennie
email us here

Source: EIN Presswire

New White Paper Details Bureaucracy, Deadly Delays, and Apathy by Pharmacy Benefit Managers

COA White Paper Continues to Share True Patient-PBM Stories and How They Hurt Cancer Patients

Profit-driven PBM middlemen have become a scourge on our health care system, hurting sick cancer patients that desperately need these drugs as they battle this devastating disease.”

— Ted Okon, Executive Director of COA

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, September 19, 2017 / — Today, the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) released a new white paper sharing more real patient stories detailing the negative impact pharmacy benefit managers (PBMs) have on cancer care.

Compiling stories from cancer patients and physicians, the white paper “Bureaucracy, Deadly Delays, and Apathy: Pharmacy Benefit Manager Horror Stories”, presents stories collected from community oncology practices over the last year. The serious, sometimes dangerous, stories told in the paper include PBM bureaucracies failing cancer patients through complete indifference to sick patients, dangerous mistakes, and deadly bureaucracies.

• Read the full white paper “Bureaucracy, Deadly Delays, and Apathy: Pharmacy Benefit Manager Horror Stories — Part III”.

“Profit-driven PBM middlemen have become a scourge on our health care system, hurting sick cancer patients that desperately need these drugs as they battle this devastating disease,” said Ted Okon, Executive Director of COA. “How many more horror stories must we hear before action is taken to finally stop PBM abuses? Congress needs to act now. Patients should not have to suffer because of these large, secretive bureaucracies.”

This is the third in a white paper series exposing the abuses of PBMs produced by COA. The first, “Delay, Waste, and Cancer Treatment Obstacles: The Real-Life Patient Impact of Pharmacy Benefit Managers (PBM)” was released in April at the 2017 Community Oncology Conference; the second “Unaccountable Benefit Managers: Real Horror Stories of How PBMs Hurt Patient Care” was released in June 2017.

The paper is being released during a meeting of the COA Board of Directors outside of Washington, DC. One of the areas of focus will be PBMs and the adverse impact that they are having on the care of cancer patients. It complement the website launched by COA as a place to support patient education and advocacy on PBM issues. Visitors to the site will be able to access the patient horror stories series, educational videos, and more.

Read the full white paper “Bureaucracy, Deadly Delays, and Apathy: Pharmacy Benefit Manager Horror Stories — Part III” at

Nicolas Ferreyros
Community Oncology Alliance
email us here

Source: EIN Presswire

Global Active Pharmaceutical Ingredients (API) Market 2017 Share, Trend, Segmentation And Forecast To 2022

Active Pharmaceutical Ingredients (API) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022

PUNE , MAHARASHTRA, INDIA, September 19, 2017 / — Active Pharmaceutical Ingredients (API) Industry


Wiseguyreports.Com Adds “Active Pharmaceutical Ingredients (API) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database

The Global Active Pharmaceutical Ingredients (API) market accounted for $121.4 billion in 2014 and is expected to grow at a CAGR of 6.4% to reach $198.8 billion by 2022. Patent expiration of prominent drugs, government initiatives, regional penetration, increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.The Global Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing.

By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Anti-infectives application commanded the largest market share in 2014, whereas oncology is expected to be the fastest growing application with a CAGR of more than 8.8 during the forecast period.

By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the global leader in the active pharmaceuticals ingredients market due to its highly developed research and development projects in the field of therapies, medical sciences, and drugs. Asia Pacific is projected to be the fastest growing regional market with a CAGR of more than 8%. The fast growth is attributed to patent expirations of drugs, and favourable investments in medical research.

Request for Sample Report @

Some of the prominent players in the active pharmaceutical ingredients (API) market include WuXi Apptec, Teva Pharmaceutical, Pfizer, Novartis, Mylan, BASF, Actavis, Cambrex, Dr. Reddy’s Laboratories and Novartis.

What our report offers: 
– Market share assessments for the regional and country level segments 
– Market share analysis of the top industry players 
– Strategic recommendations for the new entrants 
– Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets 
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
– Strategic recommendations in key business segments based on the market estimations 
– Competitive landscaping mapping the key common trends 
– Company profiling with detailed strategies, financials, and recent developments 
– Supply chain trends mapping the latest technological advancements

Complete report details @ 

Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Research Scope 
2.3 Research Methodology 
2.4 Research Sources 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

9 Key Developments 
9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
9.2 Acquisitions & Mergers 
9.3 New Product Launch 
9.4 Expansions 
9.5 Other Key Strategies 

10 Company Profiling 
10.1 Zoetis (U.S.) 
10.2 Merck Animal Health (U.S.) 
10.3 Merial Inc. (Sanofi) (France) 
10.4 Elanco Animal Health (U.S.) 
10.5 Boehringer Ingelheim (Germany) 
10.6 Bayer Healthcare (Germany) 
10.7 Bioniche Animal Health (Canada) 
10.8 Heska Co. (U.S.) 
10.9 Ceva Animal Health, Inc. 
10.10 Virbac

Make an enquiry before buying this report @ 


Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EIN Presswire

US Neurofeedback System 2017 – Global Market Size, Trends, Opportunities and Growth Forecast to 2022

Wiseguyreports.Com Publish New Market Research Report On-“US Neurofeedback System 2017 – Global Market Size, Trends, Opportunities and Growth Forecast to 2022”.

PUNE, INDIA, September 19, 2017 / —

US Neurofeedback System Market 2017

Executive Summary
Neurofeedback is a non-invasive method of direct brain function training. It is also a type of biofeedback and is therefore, also called EEG Biofeedback. It uses the electrodes (which act like tiny microphones) placed on the client's scalp to record and amplify the EEG, or brainwaves and control auditory, visual, and/or tactile feedback which allows learning to take place. This operant learning initiates self-regulation and enhances relaxation, both necessary components of good brain function.

Scope of the Report:
This report focuses on the Neurofeedback System in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
BrainMaster Technologies
BEE Medic
Thought Technology
Mind Media
Wearable Sensing

Request a Sample Report @

Market Segment by States, covering
New York

Market Segment by Type, covers
Slow Cortical Potential Neurofeedback (SCP-NF)
Low-energy Neurofeedback System (LENS)
Hemoencephalographic (HEG) neurofeedback

Market Segment by Applications, can be divided into
ADHD Treatment
Other Clinic Use

There are 17 Chapters to deeply display the United States Neurofeedback System market.
Chapter 1, to describe Neurofeedback System Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Neurofeedback System, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Neurofeedback System, for each state, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Complete Report Details @

Table of Contents –Analysis of Key Points

1 Market Overview
1.1 Neurofeedback System Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by States
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 BrainMaster Technologies
2.1.1 Profile
2.1.2 Neurofeedback System Type and Applications Type 1 Type 2
2.1.3 BrainMaster Technologies Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 BrainMaster Technologies News
2.2 BEE Medic
2.2.1 Profile
2.2.2 Neurofeedback System Type and Applications Type 1 Type 2
2.2.3 BEE Medic Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 BEE Medic News
2.3 Brainquiry
2.3.1 Profile
2.3.2 Neurofeedback System Type and Applications Type 1 Type 2
2.3.3 Brainquiry Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Brainquiry News
2.4 Mitsar
2.4.1 Profile
2.4.2 Neurofeedback System Type and Applications Type 1 Type 2
2.4.3 Mitsar Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Mitsar News
2.5 Thought Technology
2.5.1 Profile
2.5.2 Neurofeedback System Type and Applications Type 1 Type 2
2.5.3 Thought Technology Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Thought Technology News
2.6 Mind Media
2.6.1 Profile
2.6.2 Neurofeedback System Type and Applications Type 1 Type 2

Buy Now @

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EIN Presswire

GroomX providing softskills training for the Health Care Sector in India

GroomX providing softskills training for the Health Care Sector in India

BANGALORE, KARNATAKA, INDIA, September 19, 2017 / — Welcome to GroomX Finishing Academy. A training and development organization which provides complete end-to-end training solutions with a mission. We work with the client to provide high quality training that will seamlessly transition the employees to a higher level of competence.


Patients and their visitors depend on hospital employees to go the extra mile to provide customer service that takes into account the intimidation they feel simply visiting a hospital.
Our Training for Hospital Employees program delivers proven methods that will provide insight into how human behavior affects individual customer needs and will enable any hospital employee to provide lasting customer satisfaction to patients.


Our Training for Hospital Employees program teaches employees and the administrative staff the ability to recognize patient and visitor behavioural styles and to respond according to individual needs.
Participants who attend this session will learn the methods required to ensure that every person who visits a hospital, be it a patient or a visitor, leaves as a satisfied customer.

Soft Skill Training is Often Overlooked
When it comes to skills in employment, the first line of emphasis is typically towards abilities, training and knowledge of specific skill sets. These are referred to as hard skills. Soft skills, however, are often overlooked, yet they also play an important role in day-to-day operations.
Soft skills are personal attributes that enhance an individual’s interactions, job performance and career prospects. Unlike hard skills, which are about a person’s skill set and ability to perform a certain type of task or activity, soft skills are interpersonal and broadly applicable.
Training Process
Pre-training questionnaire is sent prior to training session.
Execution of the training.
Post-training evaluation.

Methodology :

Combination of : Role plays’ | Activities | Games | Case Studies & PPT’s | Audio & Video clips | Mockup segment’s etc.

During the sessions, training may happen but learning may not. To avoid this contradiction, we take up role of a learning facilitator by making interactive training sessions, customizing training programs that meet client’s requirements.

Few Clients : GroomX KWPL

Manipal Hospitals India | Sagar Hospital | Green Apple | Radiant Health Care |
Maharaja Agrasen Hospital | Manipal Ankur and many many more.

At GroomX, we’re talking about technology everyday—and not just with a variety of clients, but with leading vendors—about industry trends and real-life challenges.
And because of our close partnership with leading vendors, GroomX is positioned to help businesses like yours leverage our knowledge experts to discuss strategies, implementation and troubleshooting.
Continuous Up gradation : GroomX offers continuous up gradation of the trainings once designed. We also work closely with leadership team of your organisation to introduce the new trainings and modify/alter existing trainings.

Jal Dani
GroomX Knowledge Works Pvt Ltd
email us here

Source: EIN Presswire

The use of Animal Models in Pre-Clinical Drug Development

Superbugs USA 2017

Superbugs USA 2017

UNT Health Science Centre to lead interactive workshop at the next annual USA meeting on Superbugs and Superdrugs

Very enjoyable and informative meeting”

— Micromyx, Past Attendee Testimonial

ISELIN, NEW JERSEY, UNITED STATES, September 19, 2017 / — SMi Group’s USA conference on Superbugs & Superdrugs is set to return to Iselin New Jersey this fall on November 13th and 14th. Not only will the next instalment in the global series feature an agenda that hones in on expert led approaches to strengthen the antibiotic pipeline, but it will also offer hands on training through a post-conference interactive workshop taking place on November 15th.

Hosted by the UNT Health Science Centre and led by William Weiss, Director, Pre-Clinical Services; and Mark Pulse, Assistant Director; the workshop on "The Use of Animal Models in Pre-Clinical Drug Development" will focus on the transition from in vitro activity to in vivo efficacy; the choice of the right animal model for proof of concept studies; and provide examples of relevant animal models with supportive data and interpretation of results as it relates to the clinical condition.

William Weiss has extensive experience in pre-clinical microbiology research and development efforts focused on the discovery & development of new antimicrobial agents. He has worked on numerous antibacterial programs including the development of the marketed antibiotics; Suprax, Zosyn and Tygacil.

Mark Pulse has been directly involved in the development of multiple in vivo models that have included GI- and respiratory-associated infectious diseases, device-associated (biofilm) infections and pharmacokinetic studies.

Other notable speakers on the agenda will include representatives from: Janssen, BARDA, CARB-X, Pfizer, MedImmune, Visterra, Contrafect, Centauri Therapeutics, Microbiotix and Merck.

Further information on Superbugs & Superdrugs USA is available at

Superbugs & Superdrugs USA will take place on 13th & 14th November at the Renaissance Woodbrigde Hotel in Iselin, New Jersey. Sponsored by Merck and Soligenix.

— END —

Contact Information:
For all media inquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email:

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

About UNT Health Science Centre
The Pre-Clinical Services group in the UNT System College of Pharmacy at the University of North Texas Health Science Center conducts industry sponsored research studies utilizing established models of both acute and chronic bacterial infections in several different animal species including pharmacokinetic/pharmacodynamic studies with bioanalytical LCMS/HPLC analysis. Infection models or protocols other than those described herein can also be develop and validated as required to meet the more specific needs of interested Sponsors. UNTHSC Pre-clinical Services together has over 35 years of direct pharmaceutical and specialized biotech experience in the performance of therapeutic efficacy models and drug discovery/development. The group utilizes this experience to guide the drug discovery process, from protocol design to implementation and analysis for compound lead selection. Studies are conducted in state-of-the-art laboratory and vivarium facilities with excellent support staff and services.

Teri Arri
SMi Group
email us here

Source: EIN Presswire